LINKAGE GLOBAL INC (LGCB)

KYG5500B1023 - Common Stock

0.45  +0.03 (+7.58%)

After market: 0.43 -0.02 (-4.44%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LGCB. LGCB was compared to 32 industry peers in the Broadline Retail industry. LGCB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LGCB has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

LGCB had positive earnings in the past year.
In the past year LGCB has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of LGCB (9.59%) is better than 81.25% of its industry peers.
Looking at the Return On Equity, with a value of 22.39%, LGCB is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
LGCB has a Return On Invested Capital of 11.74%. This is in the better half of the industry: LGCB outperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA 9.59%
ROE 22.39%
ROIC 11.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LGCB has a Profit Margin of 4.84%. This is in the better half of the industry: LGCB outperforms 68.75% of its industry peers.
Looking at the Operating Margin, with a value of 5.52%, LGCB is in line with its industry, outperforming 53.13% of the companies in the same industry.
LGCB has a Gross Margin of 16.82%. This is amonst the worse of the industry: LGCB underperforms 90.63% of its industry peers.
Industry RankSector Rank
OM 5.52%
PM (TTM) 4.84%
GM 16.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

LGCB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.

2.2 Solvency

LGCB has an Altman-Z score of 4.21. This indicates that LGCB is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.21, LGCB is doing good in the industry, outperforming 71.88% of the companies in the same industry.
LGCB has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
LGCB has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 4.21
ROIC/WACC1.97
WACC5.97%

2.3 Liquidity

LGCB has a Current Ratio of 2.59. This indicates that LGCB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LGCB (2.59) is better than 87.50% of its industry peers.
LGCB has a Quick Ratio of 2.55. This indicates that LGCB is financially healthy and has no problem in meeting its short term obligations.
LGCB has a Quick ratio of 2.55. This is amongst the best in the industry. LGCB outperforms 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.55

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

LGCB is valuated reasonably with a Price/Earnings ratio of 9.00.
81.25% of the companies in the same industry are more expensive than LGCB, based on the Price/Earnings ratio.
LGCB is valuated cheaply when we compare the Price/Earnings ratio to 30.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9
Fwd PE N/A

4.2 Price Multiples

LGCB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LGCB is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LGCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LINKAGE GLOBAL INC

NASDAQ:LGCB (9/23/2024, 5:53:08 PM)

After market: 0.43 -0.02 (-4.44%)

0.45

+0.03 (+7.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.68M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.59%
ROE 22.39%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.52%
PM (TTM) 4.84%
GM 16.82%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.59
Quick Ratio 2.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y